Biocon informs about press release

15 Feb 2016 Evaluate

Biocon has informed about a Press Release dated February 15, 2016 titled ‘Biocon Gets its First Generic Formulation Approval in EU; On Track to Launch Rosuvastatin Tablets in FY 17’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

379.70 10.60 (2.87%)
25-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.85
Dr. Reddys Lab 1301.90
Cipla 1243.90
Zydus Lifesciences 903.60
Lupin 2347.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×